Fifth Annual Clinical Fellowship Competition from NMD4C and MDC Opens May 1st

Together, NMD4C and MDC are excited to open our 2026 annual funding competition to provide clinical fellowship award(s) in neuromuscular medicine and electromyography (EMG)!  This annual funding competition provides one-year salary support ($80, 000) for early-career clinicians to participate in Canadian neuromuscular medicine and EMG fellowship training programs.

This year, the competition dates have been modified to better align with the academic calendar of Canadian residency and fellowship training programs – please note the new spring dates for the clinical fellowship funding competition!

 

Dates and Timelines

Funding competition opens:  May 1, 2025

Application submission deadline:  June 12th, 2025

Notification of Funding: July-August 2025

Funds available: July-September 2026

 

Competition Guidelines

The 2026 competition guidelines are available on the NMD4C website, as well as information on how to submit an application.

Clinical fellowship competition guidelines

If you have any questions about the 2026 competition, please contact network manager Erin Beattie at .

 

Postdoctoral Research Fellowship Competition to Launch Fall 2025

NMD4C and MDC also hold postdoctoral fellowship awards in neuromuscular disease research as a part of our annual fellowship funding competition. These awards provide salary support for early-career scientists to conduct postdoctoral studies in a Canadian laboratory focused on NMD research. The postdoctoral fellowship competition will continue to take place in the fall. More information on how to apply for this year’s competition will be available in the fall of 2025.

2026 Clinical Neuromuscular Fellowship Competition poster

Read next...

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!

Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)

Clinical Fellowship Awardees

Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients

We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.